<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37591626</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1757-790X</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>17</Day></PubDate></JournalIssue><Title>BMJ case reports</Title><ISOAbbreviation>BMJ Case Rep</ISOAbbreviation></Journal><ArticleTitle>Reversible myelofibrosis secondary to systemic lupus erythematosus.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e255229</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bcr-2023-255229</ELocationID><Abstract><AbstractText>Pancytopenia due to systemic lupus erythematosus (SLE) is rarely reported, and among those reported, it is mostly due to immunologically mediated cell destruction. Pancytopenia due to bone marrow fibrosis secondary to SLE is an extremely rare entity. Myelofibrosis secondary to SLE per se is reported only in 21 cases in the literature. Ours probably is the 22nd case report on SLE with myelofibrosis. Primary presentation of SLE with bleeding manifestation is also a rare phenomenon. Partial to complete regression of myelofibrosis is noted following treatment in secondary myelofibrosis caused by SLE. We report a case of a woman in her late 40s who presented to us with bleeding manifestations of petechial rash and menorrhagia, which on further evaluation showed pancytopenia due to myelofibrosis secondary to SLE. Our case underlines multiple features like primary bleeding manifestation and regression of myelofibrosis following treatment which is rarely reported in association with SLE.</AbstractText><CopyrightInformation>&#xa9; BMJ Publishing Group Limited 2023. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rama Krishna Reddy</LastName><ForeName>Murali Mohan</ForeName><Initials>MM</Initials><Identifier Source="ORCID">0000-0002-6272-5694</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Kasturba Medical College Mangalore, Manipal Academy of Higher Education, Manipal, Mangalore, Karnataka, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boloor</LastName><ForeName>Archith</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4513-0215</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Kasturba Medical College Mangalore, Manipal Academy of Higher Education, Manipal, Mangalore, Karnataka, India archith.boloor@manipal.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Nikhil Kenny</ForeName><Initials>NK</Initials><Identifier Source="ORCID">0000-0002-2788-7305</Identifier><AffiliationInfo><Affiliation>Gastroenterology and Hepatology, St Luke's Hospital, Pathanamthitta, Kerala, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Case Rep</MedlineTA><NlmUniqueID>101526291</NlmUniqueID><ISSNLinking>1757-790X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055728" MajorTopicYN="Y">Primary Myelofibrosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010198" MajorTopicYN="Y">Pancytopenia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008595" MajorTopicYN="Y">Menorrhagia</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Haematology (incl blood transfusion)</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>18</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>17</Day><Hour>21</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37591626</ArticleId><ArticleId IdType="pmc">PMC10441047</ArticleId><ArticleId IdType="doi">10.1136/bcr-2023-255229</ArticleId><ArticleId IdType="pii">16/8/e255229</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kaushansky K, Lichtman MA, Prchal J, et al. . Malignant diseases chapter 89. Idiopathic myelofibrosis (myelofibrosis with myeloid Metaplasia). 9th edn. McGraw-Hill Education, 2018.</Citation></Reference><Reference><Citation>Daly HM, Scott GL. Myelofibrosis as a cause of pancytopenia in systemic lupus erythematosus. J Clin Pathol 1983;36:1219&#x2013;22. 10.1136/jcp.36.11.1219</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.36.11.1219</ArticleId><ArticleId IdType="pmc">PMC498534</ArticleId><ArticleId IdType="pubmed">6630572</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue Y, Matsubara A, Okuya S, et al. . Myelofibrosis and systemic lupus erythematosus: reversal of fibrosis with high-dose corticosteroid therapy. Acta Haematol 1992;88:32&#x2013;6. 10.1159/000204592</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000204592</ArticleId><ArticleId IdType="pubmed">1414159</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar RN, Banerjee S, Dey S, et al. . Haematological presentation of systemic lupus erythematosus. J Assoc Physicians India 2009;57:767&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">20329445</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantopoulos K, Terpos E, Prinolakis H, et al. . Systemic lupus erythematosus presenting as myelofibrosis. Haematologia (Budap) 1998;29:153&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">9728808</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal BR, Bhalla K, Dalvi R, et al. . Myelofibrosis secondary to SLE and its reversal on steroid therapy. Indian Pediatr 1995;32:1207&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">8772871</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiss E, G&#xe1;l I, Simkovics E, et al. . Myelofibrosis in systemic lupus erythematosus Leuk lymphoma. Leuk Lymphoma 2000;39:661&#x2013;5. 10.3109/10428190009113399</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10428190009113399</ArticleId><ArticleId IdType="pubmed">11342352</ArticleId></ArticleIdList></Reference><Reference><Citation>Paquette RL, Meshkinpour A, Rosen PJ. A steroid-responsive cause of bone marrow fibrosis associated with systemic lupus erythematosus. Medicine (Baltimore) 1994;73:145&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">8190037</ArticleId></ArticleIdList></Reference><Reference><Citation>Ungprasert P, Chowdhary VR, Davis MD, et al. . Autoimmune myelofibrosis with pancytopenia as a presenting manifestation of systemic lupus erythematosus responsive to mycophenolate mofetil. Lupus 2016;25:427&#x2013;30. 10.1177/0961203315615221</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203315615221</ArticleId><ArticleId IdType="pubmed">26537421</ArticleId></ArticleIdList></Reference><Reference><Citation>Foley-Nolan D, Martin MF, Rowbotham D, et al. . Systemic lupus erythematosus presenting with myelofibrosis. J Rheumatol 1992;19:1303&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">1404171</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M, Costenbader K, Daikh D, et al. . 2019 European League against rheumatism/American college of rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol 2019;71:1400&#x2013;12. 10.1002/art.40930</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40930</ArticleId><ArticleId IdType="pmc">PMC6827566</ArticleId><ArticleId IdType="pubmed">31385462</ArticleId></ArticleIdList></Reference><Reference><Citation>Vergara-Lluri ME, Piatek CI, Pullarkat V, et al. . Autoimmune myelofibrosis: an update on morphologic features in 29 cases and review of the literature. Hum Pathol 2014;45:2183&#x2013;91. 10.1016/j.humpath.2014.07.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humpath.2014.07.017</ArticleId><ArticleId IdType="pubmed">25282037</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal S, Sher MR, Good RA, et al. . Diversity in presenting manifestations of systemic lupus erythematosus in children. J Pediatr 1999;135:500&#x2013;5. 10.1016/s0022-3476(99)70174-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-3476(99)70174-5</ArticleId><ArticleId IdType="pubmed">10518085</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanitpongpun C, Teawtrakul N, Mahakkanukrauh A, et al. . Bone marrow abnormalities in systemic lupus erythematosus with peripheral Cytopenia. Clin Exp Rheumatol 2012;30:825&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23101438</ArticleId></ArticleIdList></Reference><Reference><Citation>Simeni Njonnou SR, Deuson J, Royer-Chardon C, et al. . Unexplained cause of thrombocytopenia, fever, Anasarca and hypothyroidism: TAFRO syndrome with thrombotic microangiopathy renal histology. BMJ Case Rep 2020;13. 10.1136/bcr-2019-234155</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2019-234155</ArticleId><ArticleId IdType="pmc">PMC7328895</ArticleId><ArticleId IdType="pubmed">32606113</ArticleId></ArticleIdList></Reference><Reference><Citation>Campanelli R, Massa M, Rosti V, et al. . New markers of disease progression in myelofibrosis. Cancers (Basel) 2021;13. 10.3390/cancers13215324</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13215324</ArticleId><ArticleId IdType="pmc">PMC8582535</ArticleId><ArticleId IdType="pubmed">34771488</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta K, Saeidi B, Pascal W. ANCA negative vasculitis presenting with interstitial lung disease and pancytopenia. Arch Intern Med Res 2019;02:077&#x2013;84. 10.26502/aimr.0015</Citation><ArticleIdList><ArticleId IdType="doi">10.26502/aimr.0015</ArticleId></ArticleIdList></Reference><Reference><Citation>Amissah-Arthur MB, Gordon C. Contemporary treatment of systemic lupus erythematosus: an update for Clinicians. Ther Adv Chronic Dis 2010;1:163&#x2013;75. 10.1177/2040622310380100</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2040622310380100</ArticleId><ArticleId IdType="pmc">PMC3513867</ArticleId><ArticleId IdType="pubmed">23251736</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>